The antimicrobial activity of ciprofloxacin against Legionella species and the treatment of experimental Legionella pneumonia in guinea pigs

The Journal of Antimicrobial Chemotherapy
A SaitoM Hirota

Abstract

The antimicrobial activity of ciprofloxacin was tested against 15 standard reference strains, and 37 clinical and environmental strains of Legionella pneumophila by an agar dilution method, using a new growth medium (B-SYE agar) which we devised. The minimal inhibitory concentrations of ciprofloxacin were found to be inoculum dependent, and ranged from 0.02 to 0.06 mg/l at 10(4) cfu inoculum and 0.02 by 0.125 mg/l at 10(6) cfu inoculum. The most potent antibacterial activity was shown by rifampicin, followed by ofloxacin, ciprofloxacin, enoxacin, norfloxacin, erythromycin and pipemidic acid in that order. The therapeutic efficacy of ciprofloxacin in experimental guinea pig pneumonia due to L. pneumophila was fairly good with a survival rate of 80%. From other data of ours, its effectiveness in experimental pneumonia was equal to or greater than that of erythromycin. Further studies would be appropriate to investigate the possibility of using ciprofloxacin for the treatment of human L. pneumophila infection.

Citations

Oct 3, 1998·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J García-de-LomasS Sánchez
Dec 11, 1987·Pharmaceutisch Weekblad. Scientific Edition·L Verbist
Apr 1, 1987·Diagnostic Microbiology and Infectious Disease·R N Jones, A L Barry
Jan 1, 1991·International Journal of Antimicrobial Agents·H H Gadebusch, D L Shungu
Jul 5, 2003·Journal of Microbiological Methods·Irma A J M Bakker-Woudenberg
Sep 1, 1988·Antimicrobial Agents and Chemotherapy·S KohnoK Hara
Dec 1, 1989·Antimicrobial Agents and Chemotherapy·P H Edelstein, M A Edelstein
Apr 1, 1989·Antimicrobial Agents and Chemotherapy·S L BarriereS M Seo
Mar 1, 1991·Antimicrobial Agents and Chemotherapy·R N SwansonJ J Clement
Feb 10, 2016·Current Infectious Disease Reports·Shobini Sivagnanam, Steven A Pergam
Nov 1, 1988·Zentralblatt Für Bakteriologie, Mikrobiologie, Und Hygiene. Series A, Medical Microbiology, Infectious Diseases, Virology, Parasitology·M Rotter, A M Hirschl
May 4, 2006·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·L Pedro-Botet, V L Yu
Feb 28, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Hayley B GershengornHannah Wunsch
May 2, 2009·Expert Opinion on Pharmacotherapy·M Luisa Pedro-Botet, Victor L Yu
Nov 2, 2005·The Journal of Antimicrobial Chemotherapy·Futoshi HigaJiro Fujita
Jul 1, 2010·Expert Review of Anti-infective Therapy·Frédéric Lamoth, Gilbert Greub
Oct 1, 1990·Journal of Chemotherapy·P MapleJ M Hamilton-Miller
Jun 13, 1998·Antimicrobial Agents and Chemotherapy·T SchülinG M Eliopoulos
Oct 1, 1989·Clinical Microbiology Reviews·J S Wolfson, D C Hooper
Jan 1, 1988·Clinical Microbiology Reviews·W C Winn

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.